Concepedia

Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer

Emmanuel Mitry, Pascal Hammel, G. Deplanque, Françoise Mornex, Philippe Levy, Jean‐François Seitz, Alain Moussy, Jean‐Pierre Kinet, Olivier Hermine, Philippe Rougier,

Cancer Chemotherapy and Pharmacology · 2010 · 59 citations · 28 references

DOI

Concepts

References

28

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

1969 Cancer Facts and Figures

American Association of Industrial Nurses Journal · 1968 · 8.9K citations

, , +11

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group

Malcolm J. Moore, David Goldstein, John Hamm et al. · Journal of Clinical Oncology · 2007 · 3.9K citations

, , +17

Hepatogastroenterology

Yong Liu, Zong-Guang Zhou, Ke-Ling Chen et al. · Hepatogastroenterology · 2012 · 2.1K citations

, , +17